Skip to content
Search

Latest Stories

CCA identifies four key pointers for delivering NHS pharmacy plans

Since the introduction of the 2019 NHS Long-Term Plan, several policy commitments have surfaced, presenting a definitive 'blueprint' for community pharmacy in England. The Company Chemists Association has identified four crucial commitments that, when integrated, hold the potential to revolutionise patient care through community pharmacies.

“Each commitment is like a crucial piece of a puzzle,” CCA said. “For the transformation of patient access through community pharmacy to be successful, all these pieces must come together harmoniously. Otherwise, the picture will remain incomplete.”


The four major pieces of the puzzle coined by CCA include:

• Building on education and training reforms to increase the size and capability of the workforce.

• Expanding the number of clinical services commissioned and delivered in community pharmacy.

• Introducing digital enablers which underpin service delivery.

• Introducing legislative changes to increase capacity and allow the delivery of more patient-facing clinical care.

“The challenges in the sector are significant,” said Malcolm Harrison, Chief Executive of the CCA. “Historic underfunding, a continued workforce crisis and continued delays in the rollout of promised efficiencies have created a perfect storm. We still need action for the ‘here and now’, otherwise the pharmacy network will continue to deteriorate.”

According to CCA, the success of any commitments depends on implementation through cooperation between policymakers and the sector. “The recent announcements in the Primary Care Recovery Plan and the NHS Workforce Plan are positive, but the focus must now shift to actual implementation.”

Furthermore, careful planning and partnership are essential to fully grasp opportunities like Independent Prescribing, CCA added.

CCA said clear goals and milestones are essential for measuring the impact of changes on patients and helping pharmacy businesses evaluate costs and benefits for further investment. “Timely and effective implementation is crucial to address the urgent needs of patients and the NHS.”

Meanwhile, the Expert Panel's report on the community pharmacy sector's funding, published on Tuesday (25 July), highlights the need for improvement. The review of nine Government commitments, including seven from the Community Pharmacy Contractual Framework, indicates inadequate funding to sustain pharmacies amidst rising demands, workforce pressures, and inflation-related costs.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less